Cliniphar (TSE:432A) Long-Term Debt: 円357 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:432A Cliniphar Ltd TSE:432A
20 GF Score
Price 円1,450.00
! 3 Warning Signs
View Full Analysis

What is Cliniphar Long-Term Debt?

Cliniphar TSE:432A 20 Long-Term Debt is 円357 Mil as of Mar. 2026. GuruFocus rates TSE:432A with a GF Score™ of 20/100. The stock has 3 warning signs investors should review.

Cliniphar's Long-Term Debt for the quarter that ended in Mar. 2026 was 円357 Mil.

Cliniphar's quarterly Long-Term Debt declined from Mar. 2025 (円937 Mil) to Sep. 2025 (円597 Mil) and declined from Sep. 2025 (円597 Mil) to Mar. 2026 (円357 Mil).

Cliniphar's annual Long-Term Debt declined from Mar. 2024 (円1,020 Mil) to Mar. 2025 (円937 Mil) and declined from Mar. 2025 (円937 Mil) to Mar. 2026 (円357 Mil).

Cliniphar  (TSE:432A) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Cliniphar Long-Term Debt Related Terms

Cliniphar Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Cliniphar's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cliniphar Long-Term Debt Chart

Cliniphar Annual Data
Trend Mar24 Mar25 Mar26
Long-Term Debt
1,020.01 936.68 356.68

Cliniphar Semi-Annual Data
Mar24 Mar25 Sep25 Mar26
Long-Term Debt 1,020.01 936.68 596.68 356.68
TSE:432A
20GF Score
Cliniphar Ltd TSE:432A
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of 円357 Mil mean?
Cliniphar (TSE:432A) has a Long-Term Debt of 円357 Mil as of Mar. 2026.
Is Cliniphar's Long-Term Debt too high?
Cliniphar's current Long-Term Debt is 円357 Mil. Overall, Cliniphar has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Cliniphar's Long-Term Debt compare to competitors?
Cliniphar's Long-Term Debt of 円357 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Cliniphar's current Long-Term Debt is 円357 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cliniphar stock overvalued right now?
Cliniphar (TSE:432A) has a current Long-Term Debt of 円357 Mil. The current Long-Term Debt is 円357 Mil. Cliniphar's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Cliniphar (TSE:432A), the current Long-Term Debt is 円357 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cliniphar Business Description

Address 1-7-31, Otemae, 5th Floor, OMM Building, Otemae, Chuo-ku, Osaka-shi, Osaka, JPN, 540-0008
Cliniphar Ltd is engaged in Pharmaceutical Wholesale and Distribution Business for Domestic and International Markets.
20GF Score

Get the complete analysis for TSE:432A

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,450.00
Price